1-15 of 15
Hongmei Jing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

B7-H6 Is Associated with Poor Prognosis and a Potential Therapeutic Target of T-Lymphoblastic Lymphoma

Lei Yuan, Lu Sun, Yu Zhao, Hongmei Jing, MD PhD, Xiaoyan Ke, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33.
DOI: https://doi.org/10.1182/blood-2020-139146
Published: 2020
Journal Articles

Efficacy and Safety Analysis of Ibrutinib-Containing Therapy for Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results from a Real-World Study in China

Qingqing Cai, PhD, Huiqiang Huang, MDPhD, Yuchen Zhang, Panpan Liu, MD PhD, Hongmei Jing, MD PhD, Ping Yang, MD PhD, Tongyu Lin, MD PhD, Zhongjun Xia, MDPhD, Zhiming Li, MD PhD, Wenyu Li, PhD, Liye Zhong, MD PhD, Xu Ye, MD PhD, Xueli Jin, MD PhD, Liling Zhang, MD PhD, Huilai Zhang, MD PhD, Xiuhua Sun, MD, Yuyang Tian, MM, Shuyun Ma, MM, Ning Su, MM, Jun Cai, BMBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
DOI: https://doi.org/10.1182/blood-2020-136842
Published: 2020
Journal Articles

Waldenström's Macroglobulinaemia in the Modern Era: Real World Outcomes and Prognostication across 35 Chinese Academic Hospitals

Xin-xin Cao, MD, Shuhua Yi, MD, Zhongxing Jiang, MD, Jingsong He, MD, Wei Yang, Juan Du, Jr., MD, Chunyan Sun, MD PhD, Yu Wu, MD, Chen Wenming, MD, Xiao-jun Liu, Bingzong Li, MDPhD, Chunrui Li, MDPhD, Wei Sang, Qin-hua Liu, Xiaoxia Chu, Li Fei, Ou Bai, Min Mao, Rong Fu, PhD, Wei WANG, MD, Lihong Liu, MD, Luqun Wang, MDPhD, Yujun Dong, MD, Jun Luo, DO, Zhenling Li, Yongqiang Wei, Qi-ke Zhang, Jing Liu, Kaiyang Ding, Liang Zou, Bi-yun Chen, Luoming Hua, PhD, Hongmei Jing, Juan He, PhD, Liang Wang, Lugui Qiu, MD, Jian Li, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
DOI: https://doi.org/10.1182/blood-2020-134785
Published: 2020
Journal Articles

Long-Term Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study

Yuqin Song, MD PhD, Yongping Song, MD, Lihong Liu, MD, Mingzhi Zhang, MD, Zhiming Li, MD PhD, Chunyan Ji, MD, Wei Xu, MD PhD, Ting Liu, MD PhD, Bing Xu, MD PhD, Xin Wang, MDPhD, Sujun Gao, Huilai Zhang, MD PhD, Yu Hu, MD, Yan Li, Ying Cheng, Haiyan Yang, MD PhD, Junning Cao, Zunmin Zhu, MD, Jianda Hu, MDPhD, Wei Zhang, Hongmei Jing, MD PhD, Kaiyang Ding, Zhengguang Lu, Bin Zhang, PhD, Renbin Zhao, PhD, Zhixin Xu, MD PhD, Jun Zhu, BS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
DOI: https://doi.org/10.1182/blood-2020-141781
Published: 2020
Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Prospective, Single-Arm, Open-Label, Multi-Center, Phase Ⅱ Clinical Trial

Yan Gao, MD PhD, Huiqiang Huang, MDPhD, Xiaoxiao Wang, Bing Bai, Yunhong Huang, MD PhD, Haiyan Yang, MD PhD, QingYuan Zhang, MD, Yufu Li, Yan Li, Min Zhou, PhD, Runxiang Yang, Bing Xu, Lihong Liu, MD, Yu Yang, MD PhD, Zhigang Peng, Ding Yu, Hui Zhou, MD PhD, Rong yan Zhang, Huilai Zhang, MD PhD, Junyuan Qi, MD, Yaming Xi, Xiaojing Xing, Zhao Wang, MD, Hongmei Jing, Xiaohong Zhang, Liping Ma, Hongyan Jin, Hongxia Yao, PhD, Yuerong Shuang, Xuefang Xia, Jianfei Xue, Chunlei Li
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
DOI: https://doi.org/10.1182/blood-2020-141752
Published: 2020
Journal Articles

Combination of Chidamide with the CHOEP Regimen in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL): A Prospective, Multicenter, Single-Arm, Phase 1b/2 Trial

Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuqin Song, Huilai Zhang, MD, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, Owen A. O'Connor, Daobin Zhou
Journal: Blood
Blood (2019) 134 (Supplement_1): 4036.
DOI: https://doi.org/10.1182/blood-2019-129305
Published: 2019
Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial

Hui-qiang Huang, Yunhong Huang, MD PhD, Gao Yan, Haiyan Yang, Qingyuan Zhang, Runxiang Yang, Min Zhou, PhD, Yufu Li, Yan Li, Lihong Liu, Hui Zhou, MD PhD, Hongmei Jing, Zhigang Peng, MD, Ding Yu, Rong yan Zhang, Bing Xu, Xiaohong Zhang, Junyuan Qi, Liping MA, MD, Shan Chen, Jianfei Xue
Journal: Blood
Blood (2019) 134 (Supplement_1): 2838.
DOI: https://doi.org/10.1182/blood-2019-126481
Published: 2019
Journal Articles

Yf-H-2015005, a New CXCR4 Antagonist, in the Mobilization of Hematopoietic Stem Cells in Patients with Non-Hodgkin Lymphoma: A Randomized-Controlled Phase 3 Study

Weiping Liu, Yufu Li, Quanshun Wang, Kaiyang Ding, Hang Su, Yue-rong Shuang, Sujun Gao, Hongmei Jing, Ye Chai, Dehui Zou, Hui Liu, Chunling Wang, Lihong LIU, Yicheng Zhang, Jinying Lin, Haiyan Zhu, Meixia Shang, Xiaoyan Yan, Chen Yao, Fengyuan Chang, Jun Zhu, MD, Yuqing Song
Journal: Blood
Blood (2019) 134 (Supplement_1): 590.
DOI: https://doi.org/10.1182/blood-2019-125456
Published: 2019
Journal Articles

Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study

Yuqin Song, MD PhD, Yongping Song, MD, Lihong Liu, Mingzhi Zhang, Zhiming Li, Chunyan Ji, Wei Xu, MD PhD, Ting Liu, MD, Bing Xu, Xin Wang, MD PhD, Sujun Gao, Huilai Zhang, MD, Yu Hu, Yan Li, Ying Cheng, Haiyan Yang, Junning Cao, MD, Zunmin Zhu, Jianda Hu, PhD, Wei Zhang, Hongmei Jing, Kaiyang Ding, Zhengguang Lu, Bin Zhang, PhD, Renbin Zhao, Zhixin Xu, Jun Zhu, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 755.
DOI: https://doi.org/10.1182/blood-2019-126305
Published: 2019
Journal Articles

4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass

Lung-Ji Chang, PhD, Lujia Dong, MD, Jun Zhu, MD, Zhitao Ying, MD, Hao-Hsian Kuo, MSc, Yuchen Liu, MSc, Yu-Qin Song, MD, Xiao-Pei Wang, MD, Yong-Qian Jia, MD, Ting Niu, MD PhD, Ting Liu, MDPhD, Ling Pan, MD, Zhuo-Gang Liu, MD, Tong Li, MD, Ying-Chun Li, MD, Kun Yao, MD, Xiaoyan Ke, MD PhD, Hongmei Jing, MD, Fang Bao, MD
Journal: Blood
Blood (2015) 126 (23): 264.
DOI: https://doi.org/10.1182/blood.V126.23.264.264
Published: 2015
Journal Articles

Detection of Circulating Plasma Cells in Multiple Myeloma with Extramedullary Plasmacytoma

Jing Wang, Shuang Geng, Yuping Zhong, MD, Mingyi Chen, MD PhD, Wenming Wang, Yuhong Pang, PhD, Jiajia Zhang, Yuanyuan Liu, Yanyi Huang, PhD, Hongmei Jing, MD
Journal: Blood
Blood (2015) 126 (23): 5328.
DOI: https://doi.org/10.1182/blood.V126.23.5328.5328
Published: 2015
Journal Articles

Up-Regulation of CAR-T Cells after G-CSF and Dexamethasone Treatment in a Defuse Large B Cell Lymphoma Patient Receiving 4SCAR19 T Cell Therapy

Hongmei Jing, MD, Lung-Ji Chang, PhD, Mingyi Chen, MD PhD, Fang Bao, MD, Jing Wang, Wenming Wang, Yuanyuan Liu, Hao-Hsian Kuo, MSc, Yuchen Liu, MSc, Lujia Dong, MD
Journal: Blood
Blood (2015) 126 (23): 5130.
DOI: https://doi.org/10.1182/blood.V126.23.5130.5130
Published: 2015
Journal Articles

5-Azacitidine Remolds the Methylation Status and Inhibits Growth in Multiple Myeloma

Wenming Wang, Jing Wang, Mingyi Chen, MD PhD, Yaoxian Liang, Zhengqian Li, Zhe Zhang, Hongmei Jing, MD
Journal: Blood
Blood (2015) 126 (23): 4817.
DOI: https://doi.org/10.1182/blood.V126.23.4817.4817
Published: 2015
Journal Articles

Single Cell RNA-Seq Reveals Clonal Consistency and Differential Malignancy in Extramedullary Plasmacytoma of Multiple Myeloma

Shuang Geng, Jing Wang, Mingyi Chen, MD PhD, Wenming Wang, Yuhong Pang, PhD, Yuanyuan Liu, Yanyi Huang, PhD, Hongmei Jing, MD
Journal: Blood
Blood (2015) 126 (23): 4808.
DOI: https://doi.org/10.1182/blood.V126.23.4808.4808
Published: 2015
Journal Articles

Circularly Permuted TRAIL (CPT) combined with Thalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma: An Open-Label, Multicenter Phase II Clinical Trial.

Wenming Chen, MD, Jian Hou, MD, PhD, Yaozhong Zhao, Lugui Qiu, MD, Xiaoyan Ke, MD, PhD, Zhao Wang, MD, PhD, Yun Leng, Hongmei Jing, Hao Xi, Xiangjun Zheng, Fuxu Wang, Bing Zhu, Shifang Yang, PhD
Journal: Blood
Blood (2012) 120 (21): 2958.
DOI: https://doi.org/10.1182/blood.V120.21.2958.2958
Published: 2012